DexCom, incorporated in Delaware and headquartered in San Diego, California, designs, manufactures, and markets continuous glucose monitoring (CGM) systems to help individuals with types 1 and 2 ...
Zacks Investment Research on MSN
Here's why you should hold DexCom stock in your portfolio for now
DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by a huge potential in the continuous glucose monitoring (CGM) market. A strong third-quarter 2025 performance and a series ...
It's true Oura partners with Palantir Technologies, a software company that serves the U.S. government. But some claims about data-sharing are false.
According to Xoriant CEO, the technology industry should move away from the AI hype cycle and deliver actual value to ...
As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...
Investor's Business Daily on MSN
Stock market today: S&P 500, Dow up, gold miners jump; AI stocks brush off Oracle drop (live coverage)
At least eight of the 30 Dow Jones components rose three points or more. They included Visa V, Goldman Sachs GS and American Express AXP. Paint giant Sherwin-Williams SHW ramped up more than four ...
Johnson & Johnson Medtech announced the expansion of its Research, Development, and Innovation (RD&I) activities at its ...
Shares of DexCom Inc. DXCM shed 1.84% to $65.73 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.16% to 6,816.51 and Dow ...
Time for the last post of 2025, as the year is almost over. I'll look back at key developments and notable products launched ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback